BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: She WH, Chok KS. Strategies to increase the resectability of hepatocellular carcinoma. World J Hepatol 2015; 7(18): 2147-2154 [PMID: 26328026 DOI: 10.4254/wjh.v7.i18.2147]
URL: https://www.wjgnet.com/1948-5182/full/v7/i18/2147.htm
Number Citing Articles
1
Francisco Tustumi, Lucas Ernani, Fabricio F. Coelho, Wanderley M. Bernardo, Sérgio S. Junior, Jaime A.P. Kruger, Gilton M. Fonseca, Vagner B. Jeismann, Ivan Cecconello, Paulo Herman. Preoperative strategies to improve resectability for hepatocellular carcinoma: a systematic review and meta-analysisHPB 2018; 20(12): 1109 doi: 10.1016/j.hpb.2018.06.1798
2
Daolin Ji, Xiangyu Zhong, Xingming Jiang, Kaiming Leng, Yi Xu, Zhenglong Li, Lining Huang, Jinglin Li, Yunfu Cui. The role of long non-coding RNA AFAP1-AS1 in human malignant tumorsPathology - Research and Practice 2018; 214(10): 1524 doi: 10.1016/j.prp.2018.08.014
3
Valtteri Kairaluoma, Niko Kemi, Vesa-Matti Pohjanen, Juha Saarnio, Olli Helminen. Tumour budding and tumour–stroma ratio in hepatocellular carcinomaBritish Journal of Cancer 2020; 123(1): 38 doi: 10.1038/s41416-020-0847-1
4
Diamantis I. Tsilimigras, Fabio Bagante, Dimitrios Moris, J. Madison Hyer, Kota Sahara, Anghela Z. Paredes, Rittal Mehta, Francesca Ratti, Hugo P. Marques, Olivier Soubrane, Vincent Lam, George A. Poultsides, Irinel Popescu, Sorin Alexandrescu, Guillaume Martel, Aklile Workneh, Alfredo Guglielmi, Tom Hugh, Luca Aldrighetti, Itaru Endo, Timothy M. Pawlik. Recurrence Patterns and Outcomes after Resection of Hepatocellular Carcinoma within and beyond the Barcelona Clinic Liver Cancer CriteriaAnnals of Surgical Oncology 2020; 27(7): 2321 doi: 10.1245/s10434-020-08452-3
5
Valtteri KAIRALUOMA, Mira KARJALAINEN, Vesa-Matti POHJANEN, Juha SAARNIO, Jarmo NIEMELÄ, Heikki HUHTA, Olli HELMINEN. Treatment trends and outcomes of hepatocellular carcinoma in a single center for 35 yearsMinerva Surgery 2021; 76(3) doi: 10.23736/S2724-5691.21.08426-1
6
Adeel S. Khan, Sandra Garcia-Aroz, Mohammad A. Ansari, Syed M. Atiq, Michael Senter-Zapata, Kathryn Fowler, M.B. Doyle, W.C. Chapman. Assessment and optimization of liver volume before major hepatic resection: Current guidelines and a narrative reviewInternational Journal of Surgery 2018; 52: 74 doi: 10.1016/j.ijsu.2018.01.042
7
Jeffrey Sum-Lung Wong, Yawen Dong, Vikki Tang, Thomas Leung, Cynthia S. Y. Yeung, Anna Tai, Ada Law, Tracy Shum, Gerry Gin-Wai Kwok, Bryan Cho-Wing Li, Roland Leung, Joanne Chiu, Ka-Wing Ma, Wong-Hoi She, Josephine Tsang, Tan-To Cheung, Thomas Yau. The Use of Cabozantinib in Advanced Hepatocellular Carcinoma in Hong Kong—A Territory-Wide Cohort StudyCancers 2021; 13(9): 2002 doi: 10.3390/cancers13092002
8
Ze-Feng Zhang, Yu-Jun Luo, Quan Lu, Shi-Xue Dai, Wei-Hong Sha. Conversion therapy and suitable timing for subsequent salvage surgery for initially unresectable hepatocellular carcinoma: What is new?World Journal of Clinical Cases 2018; 6(9): 259-273 doi: 10.12998/wjcc.v6.i9.259
9
Josephine Tsang, Jeffrey Sum Lung Wong, Gerry Gin Wai Kwok, Bryan Cho Wing Li, Roland Leung, Joanne Chiu, Tan to Cheung, Thomas Yau. Nivolumab + Ipilimumab for patients with hepatocellular carcinoma previously treated with SorafenibExpert Review of Gastroenterology & Hepatology 2021; 15(6): 589 doi: 10.1080/17474124.2021.1899808
10
Josep Marti, Massimo Giacca, Kutaiba Alshebeeb, Sumeet Bahl, Charles Hua, Jeremy C. Horn, Jad BouAyache, Rahul Patel, Marcelo Facciuto, Myron Schwartz, Sander Florman, Edward Kim, Ganesh Gunasekaran. Analysis of Preoperative Portal Vein Embolization Outcomes in Patients with Hepatocellular Carcinoma: A Single-Center ExperienceJournal of Vascular and Interventional Radiology 2018; 29(7): 920 doi: 10.1016/j.jvir.2018.01.780
11
Jiye Fan, Liying Tian, Shuhong Huang, Jing Zhang, Baohua Zhao. <p>Derlin-1 Promotes the Progression of Human Hepatocellular Carcinoma via the Activation of AKT Pathway</p>OncoTargets and Therapy 2020; : 5407 doi: 10.2147/OTT.S222895
12
Jian Zheng, Deborah Kuk, Mithat Gönen, Vinod P. Balachandran, T. Peter Kingham, Peter J. Allen, Michael I. D’Angelica, William R. Jarnagin, Ronald P. DeMatteo. Actual 10-Year Survivors After Resection of Hepatocellular CarcinomaAnnals of Surgical Oncology 2017; 24(5): 1358 doi: 10.1245/s10434-016-5713-2
13
JIN-YAN ZHANG, MING-ZHE WENG, FANG-BIN SONG, YONG-GANG XU, QI LIU, JUN-YI WU, JUN QIN, TAO JIN, JUN-MING XU. Long noncoding RNA AFAP1-AS1 indicates a poor prognosis of hepatocellular carcinoma and promotes cell proliferation and invasion via upregulation of the RhoA/Rac2 signalingInternational Journal of Oncology 2016; 48(4): 1590 doi: 10.3892/ijo.2016.3385
14
Adeel S. Khan, Kathryn Fowler, William C. Chapman. Optimizing Outcomes for Liver and Pancreas Surgery2018; : 63 doi: 10.1007/978-3-319-62624-6_4
15
Prasad WAGLE, Rajvilas NARKHEDE, Gunjan DESAI, Prasad PANDE, D R KULKARNI, Paresh VARTY. SURGICAL MANAGEMENT OF LARGE HEPATOCELLULAR CARCINOMA: THE FIRST SINGLE-CENTER STUDY FROM WESTERN INDIAABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 2020; 33(2) doi: 10.1590/0102-672020190001e1505
16
Bin Li, Yan Zhu, Lei Xie, Shuyang Hu, Shupeng Liu, Xiaoqing Jiang. Portal vein ligation alters coding and noncoding gene expression in rat liversBiochemistry and Cell Biology 2018; 96(1): 1 doi: 10.1139/bcb-2017-0070
17
Hangwei Fu, Rui Dong, Yida Zhang, Jianhua Xu, Menggang Liu, Ping Chen. Tmub1 negatively regulates liver regeneration via inhibiting STAT3 phosphorylationCellular Signalling 2019; 55: 65 doi: 10.1016/j.cellsig.2018.12.013